|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/63 | |
| C12N 15/10 | |||
| C40B 40/08 | |||
| C12N 9/22 |
| (11) | Patento numeris | 3011035 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14738672.6 |
| Europos patento paraiškos padavimo data | 2014-06-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/041790 |
| Data | 2014-06-10 |
| (87) | Numeris | WO 2014/204723 |
| Data | 2014-12-24 |
| (30) | Numeris | Data | Šalis |
| 201361836123 P | 2013-06-17 | US | |
| 201361915397 P | 2013-12-12 | US |
| (72) |
ZHANG, Feng, US
EBERT, Benjamin, Levine, US
HECKL, Dirk, DE
|
| (73) |
The Brigham and Women`s Hospital, Inc.,
75 Francis Street, Boston, MA 02115,
US
The Broad Institute, Inc., 415 Main Street, Cambridge, MA 02142, US Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, US |
| (54) | ASSAY FOR QUANTITATIVE EVALUATION OF TARGET SITE CLEAVAGE BY ONE OR MORE CRISPR-CAS GUIDE SEQUENCES |
| ASSAY FOR QUANTITATIVE EVALUATION OF TARGET SITE CLEAVAGE BY ONE OR MORE CRISPR-CAS GUIDE SEQUENCES |